Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Evaluation of the Optilite® analyser for determination of total complement activity and C3 and C4 fractions.

Nespola B, Comitogianni H, Jahn I, Goetz J.

Ann Biol Clin (Paris). 2019 Aug 1;77(4):447-452. doi: 10.1684/abc.2019.1453.

PMID:
31339492
2.

Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes.

Spielmann L, Nespola B, Séverac F, Andres E, Kessler R, Guffroy A, Poindron V, Martin T, Geny B, Sibilia J, Meyer A.

Ann Rheum Dis. 2019 Aug;78(8):1101-1106. doi: 10.1136/annrheumdis-2018-214439. Epub 2019 May 24.

PMID:
31126956
3.

Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE.

Guffroy A, Dima A, Nespola B, Poindron V, Sibilia J, Herbrecht R, De Sèze J, Habersetzer F, Andres E, Quoix E, Ohlmann P, Cribier B, Langer B, Martin T, Pasquali JL, Goetz J, Korganow AS.

Joint Bone Spine. 2016 May;83(3):330-4. doi: 10.1016/j.jbspin.2015.07.002. Epub 2015 Oct 1.

PMID:
26433710
4.

First case of amebic liver abscess 22 years after the first occurrence.

Nespola B, Betz V, Brunet J, Gagnard JC, Krummel Y, Hansmann Y, Hannedouche T, Christmann D, Pfaff AW, Filisetti D, Pesson B, Abou-Bacar A, Candolfi E.

Parasite. 2015;22:20. doi: 10.1051/parasite/2015020. Epub 2015 Jun 18.

Supplemental Content

Loading ...
Support Center